Topics:

Booming Novo Nordisk shoots for top drugmaker status

Tools

Novo Nordisk's ($NVO) CEO Lars Sorensen acknowledges there was an odd element of good fortune for the drugmaker in becoming the largest company in the Nordic region by capitalization and among the top 10 drug companies in the world. That good fortune, of course, has a flip side--an epidemic of diabetes. "What we are good at, all of a sudden becomes the biggest public health problem we have ever seen," Sorensen told the Financial Times. Report

 
Filed Under